Critically Appraising Evidence in Evidence-Based Nursing
This paper examines the ethical and philosophical responsibilities of nurses and healthcare researchers when appraising evidence for clinical practice. It argues against limiting research appraisal to a single industry-sponsored intervention — specifically alcohol-impregnated caps — and contends that true evidence-based practice requires evaluating multiple studies, comparing interventions, identifying funding conflicts, and avoiding confirmation bias. Drawing on Ioannidis (2018), Bakhit et al. (2021), and Page et al. (2019), the paper maintains that healthcare providers serve patients, not industry, and must apply rigorous critical thinking to ensure quality care.
- Introduction and the Problem of Narrow Evidence Appraisal: Senior nurses' narrow appraisal request challenged on principle
- Conflicts of Interest in Sponsored Research: Industry funding biases research toward single interventions
- The Ethical Responsibility to Appraise Broadly: Nurses must evaluate multiple interventions for quality care
- Avoiding Bias in Evidence-Based Research: Confirmation and unconscious bias undermine research integrity
- The Researcher's Core Purpose: Researchers serve patients, not commercial interests
- References: APA citations supporting the paper's arguments
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper grounds its argument in concrete ethical principles, connecting abstract ideas about research integrity to a specific clinical scenario involving industry-sponsored presentations.
- It uses an accessible analogy — the Pfizer vaccine example — to illustrate why single-intervention promotion is philosophically problematic, making the argument easy to follow for both clinical and academic audiences.
- The conclusion reinforces the paper's thesis through a series of parallel contrasting statements ("not to promote… not to show… not for the companies…"), giving the ending rhetorical force.
Key academic technique demonstrated
The paper demonstrates effective use of ethical argumentation grounded in cited literature. Rather than simply asserting that bias is bad, it explains why it matters — distinguishing between acting as a patient advocate versus acting as an agent of a commercial interest. This technique of framing a clinical issue through a principled ethical lens, supported by peer-reviewed sources, is characteristic of strong graduate-level nursing scholarship.
Structure breakdown
The paper opens by identifying a specific problematic request from senior nurses and immediately contextualizes it within conflict-of-interest concerns. It then expands to the broader ethical obligation to appraise multiple sources of evidence, uses an analogy to reinforce the argument, articulates the role of the researcher as serving patients rather than industry, and closes with a series of parallel statements restating the researcher's core purpose. References follow in APA format.
Introduction and the Problem of Narrow Evidence Appraisal
The senior nurses' request to appraise only articles discussing the use of alcohol-impregnated caps is misguided and should be resisted. It needs to be pointed out, first, that a potential conflict of interest may exist in the AACN conference luncheon where a study sponsored by the company selling the alcohol-impregnated caps was presented. Researchers need to consider who or what organization funds research — and why that matters (Ioannidis, 2018). As Bakhit et al. (2021) demonstrate, researchers must be aware that funded research can be promoted for the purpose of facilitating sales of a product, to the exclusion of other evidence-based practices that are equally effective.
Conflicts of Interest in Sponsored Research
From a philosophical and ethical perspective, the evidence-based practitioner has a responsibility to appraise articles that go beyond a single intervention — and the reason for that responsibility is that their focus must remain on achieving quality care. To focus only on one intervention is to imply that it is the only intervention that matters. It is akin to arguing that there is only one way to treat COVID-19 and that is through the Pfizer vaccine — after all, Pfizer funded several studies demonstrating the vaccine's effectiveness. Other healthcare workers, physicians, and researchers could point to numerous other interventions that are equally effective depending on the population, and they would be right to do so.
When healthcare providers place themselves solely in the hands of a single organization that stands to profit from promoting a recommended intervention, they are no longer prioritizing quality patient care — they are prioritizing profit. In doing so, the healthcare worker effectively acts as an agent of or on behalf of the company that stands to benefit commercially.
The Ethical Responsibility to Appraise Broadly
Healthcare workers and researchers are not agents of the healthcare industry; they are providers of quality care, and they must use evidence-based practice in their work. This means they must understand what the best practices are based on the totality of available evidence — and that requires looking beyond a single intervention. A single intervention promoted by an organization selling it may not inherently be problematic; it may even be an excellent intervention, or the best available one. But the researcher has to know this — which means examining other interventions, reviewing other studies, comparing and contrasting findings, and engaging in genuine critical thinking.
Always verify citation format against your institution’s current style guide requirements.